XML 60 R43.htm IDEA: XBRL DOCUMENT
v3.25.2

SUBSEQUENT EVENTS (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Dec. 31, 2024
Subsequent Events [Abstract] |  |
Schedule of black scholes option pricing model using assumptions |
Schedule of black scholes option pricing model using assumptions |  |  |
|  | At March 31, 2025 |
Grant date share price |  |  | $5.64 |
Grant date exercise price |  |  | $4.79 |
Expected term |  |  | 0.25 years |
Expected volatility |  |  | 74.1 | %
Risk-free rate |  |  | 4.32 | %
Expected dividend rate |  |  | 0 | %
Schedule of stock-based compensation |
Schedule of stock-based compensation |  |  |
|  | At March 31, 2025 |
Cash payment received from employee withholdings |  | $ | 51,781 |
Cash from employee withholdings used to purchase shares under ESPP |  |  | — |
Cash and ESPP employee withholding liability |  | $ | 51,781 |
|  | For the Three Months ended March 31, 2025 |
Cash from employee withholdings used to purchase ESPP shares |  | $ | — |
Stock based compensation expense |  |  | 21,644 |
Total increase to equity for three months ended March 31, 2025 |  | $ | 21,644 |
Schedule of warrants |
Schedule of non-plan options |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  | 1,387,775 |  |  | $ | 5.23 |  |  |  | 3.0 |  |  | $ | — |
Granted |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Forfeited |  |  | (781,323 | ) |  | $ | 5.17 |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
Exercisable at December 31, 2024 |  |  | 442,445 |  |  | $ | 5.50 |  |  |  | 1.6 |  |  | $ | 296,145 |
Outstanding at December 31, 2024 |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
Granted |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercised/Forfeited/Expired |  |  | 131,084 |  |  | $ | 5.39 |  |  |  | — |  |  | $ | — |
Outstanding at March 31, 2025 |  |  | 475,368 |  |  | $ | 5.27 |  |  |  | 2.3 |  |  | $ | 351,353 |
Exercisable at March 31, 2025 |  |  | 324,246 |  |  | $ | 5.76 |  |  |  | 1.9 |  |  | $ | 100,465 |
Warrants
Schedule of warrants |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (344,644 | ) |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | 300,000 |  |  | $ | 3.00 |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercisable at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Outstanding at March 31, 2025 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercisable at March 31, 2025 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Schedule of options activity |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
| Outstanding at December 31, 2022 |  |  |  | 926,266 |  |  | $ | 5.74 |  |  |  | 3.3 |  |  | $ | — |
| Granted |  |  |  | 463,117 |  |  | $ | 4.22 |  |  |  | 4.35 |  |  |  | — |
| Forfeited |  |  |  | (1,608 | ) |  | $ | 14.00 |  |  |  | — |  |  |  | — |
| Outstanding at December 31, 2023 |  |  |  | 1,387,775 |  |  | $ | 5.23 |  |  |  | 3.0 |  |  |  | — |
| Exercisable at December 31, 2023 |  |  |  | 581,324 |  |  | $ | 5.38 |  |  |  | 1.8 |  |  | $ | — |
| Outstanding at December 31, 2023 |  |  |  | 1,387,775 |  |  | $ | 5.23 |  |  |  | 3.0 |  |  | $ | — |
| Granted |  |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |
| Forfeited |  |  |  | (781,323 | ) |  | $ | 5.17 |  |  |  | — |  |  |  | — |
| Outstanding at December 31, 2024 |  |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
| Exercisable at December 31, 2024 |  |  |  | 442,445 |  |  | $ | 5.50 |  |  |  | 1.6 |  |  | $ | 296,145 |
Schedule of warrants |
Schedule of warrants |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (344,644 | ) |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | 300,000 |  |  | $ | 3.00 |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercisable at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Outstanding at March 31, 2025 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercisable at March 31, 2025 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Schedule of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2022 |  |  | 80,091 |  |  | $ | 8.63 |  |  |  | 0.8 |  |  |  | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (102,947 | ) |  | $ | — |  |  |  | — |  |  |  | — |
Warrants issued |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  |  | — |
Exercisable at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  |  | — |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  |  | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (344,644 | ) |  | $ | — |  |  |  | — |  |  |  | — |
Warrants issued |  |  | 300,000 |  |  | $ | 3.00 |  |  |  | 4.47 |  |  |  | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |
Exercisable at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  |  | — |

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of employee stock purchase plan activity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SubsequentEventsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration